LOCALIZATION OF OCCULT PERSISTING MEDULLARY-THYROID CARCINOMA BEFORE MICROSURGICAL REOPERATION - HIGH-SENSITIVITY OF SELECTIVE VENOUS CATHETERIZATION

被引:52
作者
FRANKRAUE, K
RAUE, F
BUHR, HJ
BALDAUF, G
LORENZ, D
ZIEGLER, R
机构
[1] UNIV HEIDELBERG,DEPT INTERNAL MED,W-6900 HEIDELBERG,GERMANY
[2] UNIV HEIDELBERG,DEPT SURG,W-6900 HEIDELBERG,GERMANY
[3] UNIV HEIDELBERG,DEPT RADIOL,W-6900 HEIDELBERG,GERMANY
[4] GERMAN CANC RES CTR,W-6900 HEIDELBERG 1,GERMANY
关键词
D O I
10.1089/thy.1992.2.113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 14 patients with occult persisting medullary thyroid carcinoma, tumor tissue was removed by microsurgical reoperation in 13 of 14 patients. This resulted in biochemical improvement in all but 1 patient and biochemical cure in 3 patients (21%). The lateral compartment of the neck or the upper mediastinum was involved in all but 1 patient. Before microsurgical reoperation, selective venous catheterization (SVC) for serum sampling along with serum calcitonin (CT) determination was done and compared to other localization methods. Tumor tissue could be localized correctly by SVC in 89% (CT gradient 1.21-2.02), computed tomography in 38%, and ultrasound in 28%. In patients with an elevated CT level after initial surgery and clinically occult disease, SVC is recommended for localization of tumor tissue. The affected side of the neck should be reoperated on with microdissection of the central and lateral compartment of the neck and the upper mediastinum. With this procedure, the cure rate of reoperation in patients with persistent occult MTC can be improved.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 23 条
  • [1] BAULIEU JL, 1987, CANCER, V60, P2189, DOI 10.1002/1097-0142(19871101)60:9<2189::AID-CNCR2820600913>3.0.CO
  • [2] 2-C
  • [3] BENMRAD MD, 1989, CANCER, V63, P133, DOI 10.1002/1097-0142(19890101)63:1<133::AID-CNCR2820630121>3.0.CO
  • [4] 2-3
  • [5] BLOCK MA, 1978, ARCH SURG-CHICAGO, V113, P368
  • [6] BUHR HJ, 1990, EUR J SURG ONCOL, V16, P366
  • [7] CLARKE SEM, 1988, J NUCL MED, V29, P33
  • [8] Frank K, 1987, Henry Ford Hosp Med J, V35, P122
  • [9] GAUTVIK KM, 1989, CANCER, V63, P175, DOI 10.1002/1097-0142(19890101)63:1<175::AID-CNCR2820630128>3.0.CO
  • [10] 2-9